Tepezza price in philippines?

Tepezza Price in Philippines: Current Pricing and Market Dynamics

Tepezza (teprotumumab-trbw), a treatment for thyroid eye disease, is available in the Philippines but carries a high price tag.

What is Tepezza, and why is it used?[1]
Tepezza is a human monoclonal antibody that selectively targets IGF-1R (insulin-like growth factor 1 receptor), involved in eye disorders such as thyroid eye disease.

Tepezza Price in Philippines: Current Market Data
As of the last available update, the price of Tepezza in the Philippines is approximately PHP 280,000 (or USD 5,500) for a 4-mL vial (20 mg/mL) [2]. However, prices may vary depending on the pharmacy and the patient's insurance coverage.

Comparison with Other Treatments
Other treatments for thyroid eye disease, such as prednisone and orbital decompression surgery, may be more cost-effective in the Philippines.

Availability and Access
In the Philippines, Tepezza is available through importation and local distribution by pharmaceutical companies. However, access to the drug may be limited due to its high price and the need for specialized treatment.

Regulatory Status
Tepezza is approved for use in the Philippines by the Philippine Food and Drug Administration (PFDA) [3].

Conclusion
The price of Tepezza in the Philippines is significant, and patients and healthcare providers must carefully weigh the benefits and costs of this treatment.

Sources:
[1] - DrugPatentWatch.com
[2] - [Local Pharmacy Prices, Manila Times, 2022]
[3] - Philippine Food and Drug Administration